Aidian – Your Aid in Diagnostics
We are a leading IVD company and offer our customers and partners the best solutions and service with a customer-focused mindset, high-quality products, and agile operations. We promote efficient and fluent healthcare by developing and manufacturing reliable, fast, and easy to use diagnostic tests for point of care.Read more about us
Latest newsView all
Tripledemic - Aidian offers tools for SARS-CoV-2, influenza A&B and RSV diagnostics
26 January 2023 | News, Product news
When time matters, rapid point of care testing can support treatment decisions
17 January 2023 | News, Product news
QuikRead go® HbA1c is a reliable and effective test for the quantitative determination of HbA1c at the point of care
A new poster about QuikRead go® HbA1c is out now! A study conducted in the Netherlands shows that QuikRead go HbA1c is very well comparable to established IFCC and NGSP reference methods.
How CRP point of care testing aids primary care and guides sustainable use of antibiotics
Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable use of antibiotics in primary care. Watch our #TestBeforePrescribing animation series addressing AMR and how CRP point of care testing benefits primary care.
SIBA® licensing and partnering opportunities
SIBA® (Strand Invasion Based Amplification) is Aidian's proprietary isothermal nucleic acid amplification technology. The technology performs at a low and constant temperature avoiding the need of complex thermal cycling instrumentation. Well established SIBA answers to increasing demands on faster and more cost effective testing methods.